Drug safety is dependent on monitoring a drug’s security after it is made available to patients (a process known as post-marketing pharmacovigilance). Less than one-third of the regulatory decisions made by the US Food and Drug Administration (FDA) are backed by published research findings or public assessments, according to a study that was just published […]
